Serina Therapeutics - SER Operating profit EBITDA

Graphic logo of Serina Therapeutics (SER)

Serina Therapeutics, Inc. (SER) is actively developing SER-214 polymer delivery systems for the treatment of Parkinson's disease, maintaining a high level of authority within the scientific community. The projected EBITDA reflects current profit dynamics, with the indicator holding around 0.00. Further growth for the biotech firm relies on successful clinical trials, patent protection, and strategic collaboration with pharmaceutical behemoths.

SER - Serina Therapeutics Profit before payment of interest, taxes and amortization over the range 11/23/2025 - 11/16/2026

Summary analytical data breakdowns for serinatherapeutics.com (SER)

- market value and analyst target forecast:
Summary company analytics:SER, Serina Therapeutics
Manufactured products of Serina Therapeutics, Inc.

The specifics of biotechnology development for neurology provide Serina Therapeutics, Inc. (SER) with high macro-stability and independence from economic cycles. This indicator captures the actual cash flow from core operations, allowing for an assessment of the adaptability of commercial processes to regulatory changes, while the company's total operating profit serves as a tool for monitoring liquidity and the risks of margin compression amid rising interest rates.

Competitor analysis for Serina Therapeutics, Inc.

JAZZ: Operating profit before amortization|Cytokinetics Corp - Operating profit EBITDA|Profit before interest, taxes and amortization PTC Therapeutics Corp|SRRK (Scholar Rock, Inc.) - Operating profit before deduction of amortization|Centessa Corp (CNTA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Dyne Therapeutics Inc|EWTX: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Rapport Corp (RAPP)|ALMS - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Kempharm ZVRA|Contineum Corp - Profit before payment of interest, taxes and amortization|LRMR - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization capricor.com|TRDA: Operating profit EBITDA|Operating profit before depreciation charges Channel PTHS|Operating profit before deduction of amortization MNOV|Profit before interest, taxes and amortization BioXcel BTAI|Profit before payment of interest, taxes and amortization ProMIS Neurosciences Inc. (PMN)|Operating profit EBITDA Apimeds Pharmaceuticals, Inc. (APUS)|Operating profit EBITDA AEON (AEON Biopharma, Inc.)|NLS Pharmaceutics AG - Profit before payment of interest, taxes and amortization|BNOX - Profit before payment of interest, taxes and amortization|HUGE (FSD Pharma Inc.) - Operating profit before amortization|RETA (Reata) - Operating profit before deduction of amortization